Page last updated: 2024-10-21

4-aminopyridine and Parkinson Disease, Secondary

4-aminopyridine has been researched along with Parkinson Disease, Secondary in 4 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Huang, CS1
Wang, GH1
Chuang, HH1
Chuang, AY1
Yeh, JY1
Lai, YC1
Yang, YC1
Haghdoost-Yazdi, H2
Piri, H1
Najafipour, R1
Faraji, A2
Fraidouni, N2
Dargahi, T1
Alipour Heidari, M1
Movahedi, M1
Hadibeygi, E1
Vaezi, F1
Kearney, JA1
Albin, RL1

Other Studies

4 other studies available for 4-aminopyridine and Parkinson Disease, Secondary

ArticleYear
Conveyance of cortical pacing for parkinsonian tremor-like hyperkinetic behavior by subthalamic dysrhythmia.
    Cell reports, 2021, 04-20, Volume: 35, Issue:3

    Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepro

2021
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
    Neurosciences (Riyadh, Saudi Arabia), 2017, Volume: 22, Issue:1

    Topics: 4-Aminopyridine; Animals; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug

2017
Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.
    Behavioural brain research, 2011, Sep-30, Volume: 223, Issue:1

    Topics: 4-Aminopyridine; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Drug Interactions;

2011
Intrasubthalamic nucleus metabotropic glutamate receptor activation: a behavioral, Fos immunohistochemical and [14C]2-deoxyglucose autoradiographic study.
    Neuroscience, 2000, Volume: 95, Issue:2

    Topics: 4-Aminopyridine; Amino Acids, Dicarboxylic; Animals; Antimetabolites; Autoradiography; Behavior, Ani

2000